Four patents currently held, every record listed here
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2038. from the record
Of the 2 now held by other companies, 2 name GB Sciences Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2038
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2020 to 2039.
US 10,857,107
Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders
Jan 31, 2038
US 11,980,592
Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases
Apr 9, 2038
US 10,653,640
Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases
Oct 23, 2038
US 11,260,044
TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes
May 22, 2039
20242028203220362039
5 pending applications: term is not computable until grant.Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2038 · High confidence
Also notable
Ends Jan 2038 · High confidence
Also notable
Ends May 2039 · High confidence
Myrcene-Containing Complex Mixtures Targeting TRPV1
US 10,709,670
The earliest of the three still in force, granted 2020 and renewed since. Its term ends first, in 2038.
Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders
US 10,857,107
The earliest of the three still in force, granted 2020 and renewed since. Its term ends first, in 2038.
TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes
US 11,260,044
The newest of the three, granted 2022. It anchors the portfolio to 2039, later than anything else here.
Formerly held, still cited
Notable
Ends Oct 2038 · High confidence
The newest of the three, granted 2020. It anchors the portfolio to 2038, later than anything else here.
now held by GB Sciences, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 2, 2027The maintenance fee for Myrcene-Containing Complex Mixtures Targeting TRPV1 (US 11,944,593) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Myrcene-Containing Complex Mixtures Targeting TRPV1 | 2 in force | to Apr 2039 |
| TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes | 1 in force | to May 2039 |
| Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders | 1 in force | to Jan 2038 |
Patents held now
Soonest term end first.
Showing 1 to 4 of 4
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,857,107 | Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders In force · High confidence | In force | High confidence | |
| US 10,709,670 | Myrcene-Containing Complex Mixtures Targeting TRPV1 In force · High confidence | In force | High confidence | |
| US 11,944,593 | Myrcene-Containing Complex Mixtures Targeting TRPV1 In force · High confidence | In force | High confidence | |
| US 11,260,044 | TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes In force · High confidence | In force | High confidence |
Also on record, not counted in the 4: 2 patents in force now held by others · 5 applications pending · 8 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.